Magnetic resonance spectroscopy guided brain tumor resection: Differentiation between recurrent glioma and radiation change in two diagnostically difficult cases

Canadian Journal of Neurological Sciences

Volumn 25, Issue 1, 1998, Pages 13-22

  Preul, Mark C ^a   Leblanc, Richard ^a   Caramanos, Zografos ^a   Kasrai, Reza ^a   Narayanan, Sridar ^a   Arnold, Douglas L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; GLIOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0031942920     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100033436     Document Type: Article

References (46)

1. Preul MC, Collins DL, Arnold DL. Differential diagnosis of human intracranial tumors in vivo using 1H-MR spectroscopic imaging and feature space for spectral pattern recognition. In: Shorvon SD, Fish DR, Andermann F, Bydder GM, Stefan H, eds. Magnetic Resonance Scanning and Epilepsy. New York: Plenum, 1993: 299-313.
2. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Medicine 1996; 2: 323-325.
3. Preul MC, Narayanan S, Comeau R, et al. Intraoperative, interactive guidance of stereotactic brain tumor biopsy or resection using in vivo biochemical image - anatomical image integration. J Neurosurg 1996; 84: 344A.
4. Preul MC, Caramanos Z, Leblanc R, et al. Improved stereotactic brain tumor biopsy or resection using in vivo biochemical imaging: accurate prediction of regional tissue chemicopathological characteristics leads to more accurate target planning. J Neurosurg 1997; 86: 361A-362A.
5. Heesters MA, Kamman RL, Mooyaart EL, Go KG. Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy. J Neurooncol 1993; 17: 27-35.
6. Wald LL, Nelson SJ, Day MR, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. Journal of Neurosurgery 1997; 87: 525-534.
7. Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. Journal of Neurosurgery 1997; 87: 516-524.
8. Culver KW, Rom Z, Wallbridge S, et al. In vivo gene transfer with retroviral-producer cells for the treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
9. Moolten FL, Wells JM. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. Journal of the National Cancer Institute 1990; 82: 297-300.
10. Ezzedine ZD, Martuza RL, Platika D, et al. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex thymidine kinase gene. New Biologist 1991; 3: 608-614.
11. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfreld EH. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Research 1993; 53: 83-88.
12. Sandoz Pharma Ltd. Study no. GLIB 201-E-00 Gene therapy for the treatment of glioblastoma multiforme with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Sandoz Pharma Ltd 1995.
13. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992; 185: 675-686.
14. Furuya S, Naruse S, Ide M, et al. [The clinical application of multivoxel 1H-CSI (chemical shift imaging) in brain tumors]. [Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 1991; 51: 836-838.
15. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET [see comments]. Radiology 1990; 177: 633-641.
16. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996; 84: 449-458.
17. Kauppinen RA, Williams SR. Nuclear magnetic resonance spectroscopy studies of the brain. [Review]. Prog Neurobiol 1994; 44: 87-118.
18. Klein J, Koppen A, Loffelhoz K, Schmitthenner J. Uptake and metabolism of choline by rat brain after acute choline administration. Journal of Neurochemistry 1992; 58: 870-876.
19. Sibson R. Studies in the robustness of multidimensional scaling: Procrustes statistics. Journal of the Royal Statistical Society 1978; 40: 234-238.
20. Collingnon A, Maes F, Delaere D, et al. Automated muli-modality image registration based on information theory. Information Processing in Medical Imaging 1995; proceedings: 263-274.
21. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3-D intersubject registration of MR volumetric data in standardized Talairach space. Journal of Computer Assisted Tomography 1994; 18: 192-205.
22. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993; 17: 536-546.
23. Neelin P, Crossman J, Hawkes DJ, Ma Y, Evans AC. Validation of an MRI/PET landmark registration method using 3D simulated PET images and point simulations. Computerized Medical Imaging and Graphics 1993; 17: 351-356.
24. Evans AC, Marrett S, Torrescorzo J, Ku S, Collins DL. MRI-PET correlation in three dimensions using a volume of interest (VOI) atlas. Journal of Cerebral Blood Flow and Metabolism 1991; 11: A69-A78.
25. Alexander E 3rd, Loeffler JS, Schwartz RB, et al. Thallium-210 technetium-99m HMPAO single-photon emission computed tomography (SPECT) imaging for guiding stereotactic craniotomies in heavily irradiated mailgnant glioma patients. Acta Neurochirurgica (Wien) 1993; 122: 215-217.
26. Buchpiguel CA, Alavi JB, Alavi A, Kenyon LC. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain [clinical conference]. Journal of Nuclear Medicine 1995; 36: 159-164.
27. Schwartz RB, Carvalho PA, Alexander E 3rd, et al. Radiation necrosis vs. high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201TI and 99mTc-HMPAO. American Journal of Neuroradiology 1991; 12: 1187-1192.
28. Tyler JL, Villemure JG, Evans AC, et al. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. Journal of Nuclear Medicine 1987; 28: 1123-1133.
29. Janus TJ, Kim EE, Tilbury R., et al. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Annals of Neurology 1993; 33: 540-548.
30. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. RAdiology 1994; 191: 41-51.
31. Preul MC, Caramanos Z, Collins DL, Arnold DL. Linear discriminant analysis based on proton MR spectroscopic imaging of human brain tumors improves pre-operative diagnosis. Proc Soc Magn Reson 1994; 2: 125 (Abstract).
32. Luyten PR, Marien AJH, Heindel W, et al. Metabolic imaging of patients with intracranial tumors 1H MR spectroscopic imaging and PET. RAdiology 1990; 176: 791-799.
33. Cristensen H, Lour HO, Clausen J, Biering F. Phospholipids and glycolipids of tumors of the central nervous system. Journal of Neurochemistry 1965; 12: 614-627.
34. Miller BL, Chang L, Booth R. In vivo 1H-MRS choline: correlation with in vitro chemistry/histology. Life Sciences 1996; 58: 1929-1935.
35. Kuesel AC, Donnelly SM, Halliday W, Sutherland GR, Smith IC. Mobile lipids and metabolic heterogeneity of brain tumors as detectable by ex vivo 1H MR spectroscopy. NMR Biomed 1994; 7: 172-180.
36. Usenius JP, Kauppinen RA, Vainio PA, et al. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 1994; 18: 705-713.
37. Remy C, Arus C, Ziegler A, et al. In vivo, ex vivo, and in vitro one-and two-dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: assignment of resonances. J Neurochem 1994; 62: 166-179.
38. Peeling J, Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992; 24: 123-136.
39. Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J Comput Assist Tomogr 1990; 14: 497-504.
40. Steen RG. Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. Cancer Research 1989; 49: 4075-4085.
41. Demaerel P, Johannik K, Van Hecke P, et al. Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991; 15: 67-76.
42. Arnold DL, Shoubridge EA, Villemure JG, Feindel W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading. NMR Biomed 1990; 3: 184-189.
43. Segebarth CM, Baleriaux DF, Luyten PR, den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1H NMR spectroscopic imaging. Magn Reson Med 1990; 13: 62-76.
44. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors [see comments]. Radiology 1989; 172: 541-548.
45. Usenius JP, Tuohimetsa S, Vainio P, et al. Automated classification of human brain tumors by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. Neuroreport 1996; 7: 1597-1600.
46. Kuesel AC, Sutherland GR, Halliday W, Smith IC. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 1994; 7: 149-155.